Charing Cross Hospital is an acute general teaching hospital located in Hammersmith, London, United Kingdom. The present hospital was opened in 1973, although it was originally established in 1818, approximately five miles east, in central London.

There are 511 beds in Charing Cross Hospital.

During the past decade, Charing Cross Hospital conducted 94 clinical trials. In the 10-year time frame, 94 clinical trials started and 38 clinical trials were completed, i.e. on average, 40.4% percent of trials that started reached the finish line to date. In the past 5 years, 33 clinical trials started and 28 clinical trials were completed. i.e. 84.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Charing Cross Hospital" #1 sponsor was "Imperial College London" with 24 trials, followed by "Hoffmann-La Roche" with 15 trials sponsored, "University College, London" with 14 trials sponsored, "Institute of Cancer Research, United Kingdom" with 8 trials sponsored and "European Organisation for Research and Treatment of Cancer - EORTC" with 8 trials sponsored. Other sponsors include 100 different institutions and companies that sponsored additional 75 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Charing Cross Hospital" #1 collaborator was "Cancer Research UK" with 9 trials as a collaborator, "AstraZeneca" with 7 trials as a collaborator, "Imperial College Healthcare NHS Trust" with 4 trials as a collaborator, "Medical Research Council" with 4 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 4 trials as a collaborator. Other collaborators include 87 different institutions and companies that were collaborators in the rest 81 trials.

According to Clinical.Site data, the most researched conditions in "Charing Cross Hospital" are "Breast Cancer" (16 trials), "Prostate Cancer" (10 trials), "Colorectal Cancer" (7 trials), "Alzheimer's Disease" (6 trials) and "Lung Cancer" (5 trials). Many other conditions were trialed in "Charing Cross Hospital" in a lesser frequency.

Most popular intervention types in "Charing Cross Hospital" are "Drug" (114 trials), "Other" (24 trials), "Device" (23 trials), "Procedure" (20 trials) and "Biological" (11 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (23 trials), "adjuvant therapy" (9 trials), "cyclophosphamide" (7 trials), "fluorouracil" (7 trials) and "Abemaciclib" (5 trials). Other intervention names were less common.

The vast majority of trials in "Charing Cross Hospital" are 137 trials for "All" genders, 20 trials for "Female" genders and 15 trials for "Male" genders.

Currently, there are NaN active trials in "Charing Cross Hospital". undefined are not yet recruiting, 33 are recruiting, 26 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 64 completed trials in Charing Cross Hospital, undefined suspended trials, and 21 terminated clinical trials to date.

Out of the total trials that were conducted in Charing Cross Hospital, 5 "Phase 1" clinical trials were conducted, 42 "Phase 2" clinical trials and 74 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 25 trials that are defined as “Not Applicable".